Brief: Processa Pharmaceuticals Gives Update On Phase 2 Study Of Metastatic Breast Cancer
17/12/2025 13:39
Dec 17 (Reuters) - Processa Pharmaceuticals Inc PCSA.O: PROCESSA PHARMACEUTICALS PROVIDES CLINICAL UPDATE ON PHASE 2 STUDY IN METASTATIC BREAST CANCER PROCESSA PHARMACEUTICALS INC -PRELIM PHASE 2 DATA SHOW PCS6422+CAPECITABINE INCREASED CANCER-KILLING METABOLITE EXPOSURE PROCESSA PHARMACEUTICALS INC - ON TRACK TO CONDUCT FORMAL INTERIM ANALYSIS IN EARLY 2026 Source text: ID:nGNX8PjgJD Further company coverage: PCSA.O ((Reuters.Briefs@thomsonreuters.com;))